TRIAL DIAL
LIVE

Serial Number

87789455

Owner

MEDIDATA SOLUTIONS, INC.

Attorney

Jordan A. LaVine

Filing Date

Feb 8, 2018

Add to watchlist:

No watchlists yet
View on USPTO

TRIAL DIAL Trademark

Serial Number: 87789455 • Registration: 5711201

TRIAL DIAL is a trademark filed by MEDIDATA SOLUTIONS, INC. on February 8, 2018. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MEDIDATA SOLUTIONS, INC. (124 trademarks)

350 Hudson Street, 9th Floor
New York, NY 10014

Entity Type: 03

Trademark Details

Filing Date

February 8, 2018

Registration Date

March 26, 2019

Published for Opposition

June 19, 2018

Goods & Services

Cloud computing featuring software for use with managing, gathering, organizing, and sharing data, information and images in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medial research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; Consulting services for others in the field of design, planning, and implementation project management of clinical trials and medical research; Providing a website featuring educational information in the field of clinical research; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing temporary use of on-line non-downloadable cloud computing software for managing, gathering, organizing, and sharing data, information and images in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medial research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; Software as a service (SAAS) services featuring software for managing, gathering, organizing, and sharing data, information and images in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medial research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 26, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 26, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 26, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 9, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 26, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 26, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 21, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 20, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 5, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 4, 2019 AITU
USE AMENDMENT FILED
Jan 9, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 9, 2019 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 14, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 19, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jun 19, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 30, 2018 NONP
ASSIGNED TO LIE
May 13, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
May 3, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 3, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
May 3, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 3, 2018 CNEA
ASSIGNED TO EXAMINER
May 2, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 16, 2018 NWOS
NEW APPLICATION ENTERED
Feb 12, 2018 NWAP